Testing effectiveness (Phase 2)Study completedNCT04900363What this trial is testingA Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLCWho this might be right forNon-small Cell Lung Cancer Akeso 108
Not applicableUnknownNCT02648087What this trial is testingPrevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung CancerWho this might be right forBronchial Cancer University Hospital, Angers 1,200
Early research (Phase 1)Looking for participantsNCT07130916What this trial is testingAumolertinib in European Participants With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Not applicableLooking for participantsNCT06967532What this trial is testingEfficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC PatientsWho this might be right forNSCLC (Non-small Cell Lung Cancer) Medical University of Vienna 90
Not applicableStudy completedNCT01775514What this trial is testingA Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment CharacteristicsWho this might be right forCancer Hoffmann-La Roche 32,277
Testing effectiveness (Phase 2)Study completedNCT02247349What this trial is testingBMS-986012 in Relapsed/Refractory SCLCWho this might be right forSmall Cell Lung Cancer Bristol-Myers Squibb 106
Not applicableStudy completedNCT00003329What this trial is testingIdentification of Genes Associated With Cancer in Patients and Siblings Who Have CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00069875What this trial is testingA Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 195
Not applicableStudy completedNCT03782207What this trial is testingA Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeWho this might be right forUrothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more Hoffmann-La Roche 2,756
Testing effectiveness (Phase 2)Study completedNCT01130753What this trial is testingEfficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung CancerWho this might be right forLung NeoplasmsErlotinibNeoadjuvant Therapy Samsung Medical Center 43
Testing effectiveness (Phase 2)UnknownNCT01210053What this trial is testingSunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Third Military Medical University 30
Early research (Phase 1)Looking for participantsNCT06800339What this trial is testingA Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer University of Maryland, Baltimore 18
Post-approval studies (Phase 4)UnknownNCT02404675What this trial is testingHigh Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon MutationWho this might be right forNSCLC Betta Pharmaceuticals Co., Ltd. 240
Not applicableApproved For MarketingNCT04599712What this trial is testingPre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung CancerWho this might be right forMetastatic Non-Small Cell Lung Cancer Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT00126581What this trial is testingErlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerWho this might be right forLung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more National Cancer Institute (NCI) 188
Not applicableEnded earlyNCT01567722What this trial is testingCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesWho this might be right forLung CancerLymphoma AIDS Malignancy Consortium 114
Early research (Phase 1)Study completedNCT03421353What this trial is testingAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerWho this might be right forAdvanced Solid Tumours AstraZeneca 76
Very early researchUnknownNCT05886075What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsWho this might be right forLung CancerBronchial CancerNon Small Cell Lung Cancer+9 more Shanghai Yunying Medical Technology 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Early research (Phase 1)Not Yet RecruitingNCT07318636What this trial is testingNK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLCWho this might be right forResectable Non-small Cell Lung Cancer The First Affiliated Hospital of Guangzhou Medical University 10